Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 8/20 | 1.00 |
| ▸ | DRD3 | P35462 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 2/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | HRH1 | P35367 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.97 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Talipexole SCHEMBL5605621 | 1.00 | DRD2 (1.00) | DRD2DRD3MAPTADRA2AADRA2B | |
| Talipexole SCHEMBL385161 | 0.98 | MAPT (1.00) | DRD2DRD3MAPTADRA2AADRA2B | |
| Talipexole SCHEMBL18203528 | 0.98 | MAPT (1.00) | DRD2DRD3MAPTADRA2AADRA2B | |
| Talipexole SCHEMBL423325 | 0.98 | MAPT (1.00) | DRD2DRD3MAPTADRA2AADRA2B | |
| Talipexole SCHEMBL678761 | 0.97 | DRD2 (0.94) | DRD2DRD3MAPTADRA2AADRA2B | |
| SCHEMBL563307 | 0.79 | RAD52 (0.79) | DRD2DRD3MAPTADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL10652670 | 0.78 | RAD52 (0.77) | DRD2DRD3MAPTADRA2AADRA2B | |
| SCHEMBL7292466 | 0.76 | DRD2 (0.60) | DRD2DRD3MAPTADRA2AADRA2B | |
| SCHEMBL7294700 | 0.76 | LMNA (0.60) | DRD2DRD3MAPTADRA2AADRA2B | |
| SCHEMBL7285804 | 0.76 | LMNA (0.60) | DRD2DRD3MAPTADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3445 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704839-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | ALPHERABIO LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-12521398-B2 | Composition for treating synucleinopathies | STANDIGM INC. (KR) | 2026-01-13 | — | — | US | claimed |
| EP-4673215-A1 | GBA1 AND GCS DUAL MODULATOR | ONO Pharmaceutical Co., Ltd. (JP) | 2026-01-07 | — | — | EP | claimed |
| US-20250213593-A1 | Use of Derivatives based on Sarsasapogenin Structure and Pharmaceutical Compositions thereof | BEIJING PHYTOVENT PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2025-07-03 | — | — | US | claimed |
| US-20250186415-A1 | EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS | FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT | 2025-06-12 | — | — | US | claimed |
| EP-4558622-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-120051560-A | Methods and compositions for generating human midbrain dopaminergic neurons from neural progenitor cells | 特雷尔赫德生物系统股份有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025080559-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC. (US) | 2025-04-17 | — | — | WO | claimed |
| US-20250114370-A1 | METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE | ENALARE THERAPEUTICS INC (US) | 2025-04-10 | — | — | US | claimed |
| EP-4489858-A1 | EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS | Harrow IP, LLC (US) | 2025-01-15 | — | — | EP | claimed |
| US-4826686-A | TRANSDERMAL PATCH FOR SUSTAINED RELEASE OF HYPOTENSIVE AGENT | BOEHRINGER INGELHEIM KG (DE) | 1989-05-02 | — | — | US | claimed |
| US-4783456-A | A-ADRENERGIC BLOCKING AGENTS | RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. (US) | 1988-11-08 | — | — | US | claimed |
| EP-0005732-B1 | Use of 2-amino-oxazolo- or 2-amino-thiazolo-[5,4-d]azepines and acid-addition salts thereof for the manufacture of a medicament for the treatment of Angina Pectoris | Dr. Karl Thomae GmbH (DE) | 1988-06-15 | — | — | EP | claimed |
| US-4707475-A | 2-AMINO-6-ALLYL-5,6,7,8-TETRAHYDRO-4H-THIAZOLO(5,4-D)AZEPINE | BOEHRINGER INGELHEIM KG (DE) | 1987-11-17 | — | — | US | claimed |
| EP-0227988-A2 | Therapeutic system | BOEHRINGER INGELHEIM KG (DE) | 1987-07-08 | — | — | EP | claimed |
| US-4645770-A | Agent for treating Parkinson's disease or Parkinsonism | BOEHRINGER INGELHEIM KG (DE) | 1987-02-24 | — | — | US | claimed |
| EP-0195888-A2 | Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[5,4-d]azepin in the reduction of prolactin serum levels | BOEHRINGER INGELHEIM KG (DE) | 1986-10-01 | — | — | EP | claimed |
| EP-0192098-A2 | Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepin for the preparation of a medicament for the treatment of Parkinson's disease, or of parkinsonism | BOEHRINGER INGELHEIM KG (DE) | 1986-08-27 | — | — | EP | claimed |
| US-4400378-A | THIAZOLO OR OXAZOLO COMPOUNDS | KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-08-23 | — | — | US | claimed |
| US-4259342-A | HYPOTENSIVE, SEDATIVE, ANTITUSSIVE, ANTIINFLAMMATORY | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-31 | — | — | US | claimed |